ArticleFrontiers in immunology2021

An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection.

Peter A van der Ley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.